Patents expiring in 2034

US 8697699

Imidazopyrazine SYK inhibitors

GILEAD CONNECTICUT, INC. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697407

Compositions and methods for inhibiting MMSET

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697034

Hyperpolarized 89-yttrium and methods relating thereto

The Board of Regents of the University of Texas System · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697628

Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697079

IgE antibodies for the treatment of cancer

The Regents of the University of California · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697138

Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

Aker Biomarine AS · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697348

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

The Regents of the University of California · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697633

Dissolution of arterial plaque

Atheronova Operations, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697689

Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors

Addex Pharma, S.A. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697698

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697666

Anti-cancer oligodeoxynucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697727

N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697662

Methods for treating Kaposi sarcoma

PTC THERAPEUTICS, INC. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697649

Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides

China Medical University · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697724

Crystalline oxalate salts of a diamide compound

Theravance, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697853

TAL effector-mediated DNA modification

Regents of the University of Minnesota · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697874

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697848

Method for reducing immunogenicity of therapeutic protein compositions

The Regents of the University of Colorado · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697858

Antisense antiviral compound and method for treating influenza viral infection

Sarepta Therapeutics, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697730

5-lipoxygenase activating protein (FLAP) inhibitor

Panmira Pharmaceuticals, LLC · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697709

Fused ring heteroaryl kinase inhibitors

The Regents of the University of California · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8697865

Cyclic amide derivative, and its production and use

Takeda Pharmaceutical Company Limited · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2883399

REDUCTION AU MINIMUM DE DEPOTS LIPIDIQUES BIOLOGIQUES SUR DES LENTILLES DE CONTACT

BAUSCH & LOMB [US] · Granted Thu Apr 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703186

Abuse-resistant oral dosage forms and method of use thereof

Elite Laboratories, Inc. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703200

Inhibition of neovascularization by cerium oxide nanoparticles

The Board of Regents of the University of Oklahoma · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703727

Nanotechnology formulation of poorly soluble compounds

Aphios Corporation · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703726

Methods for treating prostate conditions

PTC THERAPEUTICS, INC. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703756

Synthetic procedure and cancer treatment with cisplatin derivatives

THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703735

Antisense antiviral compounds and methods for treating a filovirus infection

Sarepta Therapeutics, Inc. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703791

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703208

Nanometer mesoporous silica-based xerogel styptic process and its preparing process and application

East China University of Science and Technology · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703762

Method of treating organophosphorous poisoning

The United States of America as repr. by the Sec. of the Army, U.S. Army Med. Resr. Inst. of Chem. Defense · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703800

Nitrate and diazeniumdiolate derivatives of pioglitazone

CARDIOLYNX AG · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703987

Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate

Draximage Limited · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703751

Androstenediol as an indicator for assessing estrogenicity

The Regents of the University of California · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703758

Bicyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703938

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703921

Compositions and methods for delivering inhibitory oligonucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703826

Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703920

Fully human antibodies against N-cadherin

The Regents of the University of California · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703730

Complement antagonists and uses thereof

REGENESANCE B.V. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703192

Dosage form containing pantoprazole as active ingredient

TAKEDA GMBH · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703150

Methods of using Bacillus anthracis protective antigen sequences for vaccination

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703098

Labelled adrenomedullin derivatives and their use for imaging and therapy

INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703840

Dental adhesive material kit

KURARAY NORITAKE DENTAL INC. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703136

Complement inhibition for improved nerve regeneration

REGENESANCE B.V. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703115

Methods for preparing conjugates

Nektar Therapeutics · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8703096

Beta-amyloid PET imaging agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)